Efficacy of PD-1 inhibitors combined with pegylated liposomal doxorubicin and dacarbazine compared with liposomal doxorubicin and dacarbazine in advanced leiomyosarcoma patients: a retrospective, single-institutional cohort study

BACKGROUND: PD-1 inhibitor monotherapy is ineffective for metastatic leiomyosarcoma (LMS), but it remains unclear whether PD-1 inhibitors demonstrate any efficacy when combined with chemotherapy. This study retrospectively evaluated pegylated liposomal doxorubicin (PLD) and dacarbazine (DTIC) with/w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Zhichao, Wang, Xinyu, Liu, Jiayong, Fan, Zhengfu, Gao, Tian, Bai, Chujie, Xue, Ruifeng, Li, Shu, Zhang, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577773/
https://www.ncbi.nlm.nih.gov/pubmed/36267735
http://dx.doi.org/10.21037/atm-22-3963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577773/
https://www.ncbi.nlm.nih.gov/pubmed/36267735
http://dx.doi.org/10.21037/atm-22-3963

Ejemplares similares